Home
>
National Drug Code (NDC)
>
POTIGA
POTIGA - 0173-0813-59 - (ezogabine)
Drug Information of POTIGA
| Product NDC: | 0173-0813 |
| Proprietary Name: | POTIGA |
| Non Proprietary Name: | ezogabine |
| Active Ingredient(s): | 300 mg/1 & nbsp; ezogabine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of POTIGA
| Product NDC: | 0173-0813 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022345 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120419 |
Package Information of POTIGA
| Package NDC: | 0173-0813-59 |
| Package Description: | 90 TABLET, FILM COATED in 1 BOTTLE (0173-0813-59) |
NDC Information of POTIGA
| NDC Code | 0173-0813-59 |
| Proprietary Name | POTIGA |
| Package Description | 90 TABLET, FILM COATED in 1 BOTTLE (0173-0813-59) |
| Product NDC | 0173-0813 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ezogabine |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120419 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | EZOGABINE |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Potassium Channel Openers [MoA],Potassium Channel Opener [EPC] |
